Carbonic anhydrase inhibitors and their therapeutic potential

HEWETT-EMMETT D, 1996, Mol Phyl. Evol, 5, 50, 10.1006/mpev.1996.0006

SMITH KS, 1999, Proc. Natl. Acad. Sci. USA, 96, 15184, 10.1073/pnas.96.26.15184

CABISCOL E, 1995, J. Biol. Chem., 270, 14742, 10.1074/jbc.270.24.14742

PARKKILA AK, 1998, J. Biol. Chem., 273, 24620, 10.1074/jbc.273.38.24620

BAIRD TT, 1997, Biochemistry, 36, 2669, 10.1021/bi962663s

PASTOREKOVA S, 1997, Gastroenter-ology, 112, 398, 10.1053/gast.1997.v112.pm9024293

EARNHARDT JN, 1998, Biochemistry, 30, 10387

BELLINGHAM J, 1998, 3. Biochem. Biophys. Res. Commun., 253, 364, 10.1006/bbrc.1998.9449

TURECI O, 1998, Proc. Nail Acad. ScL USA, 95, 7608, 10.1073/pnas.95.13.7608

MORI K, 1999, J. Biol. Chem., 274, 15701, 10.1074/jbc.274.22.15701

BRIGANTI F, 1999, Biol. Inorg. Chem., 4, 528, 10.1007/s007750050375

BEYER KH, 1961, PharmacoL Rev., 13, 517

REISS WG, 1996, Ann. Pharmacother., 30, 514, 10.1177/106002809603000515

LARSON EB, 1982, Clinical efficacy and effect on ventilation.J. Am. Med. Ass., 248, 328

LILJAS A, 1994, Recent crystallographic analyses. Eur. J. Biochem., 219, 1, 10.1111/j.1432-1033.1994.tb19909.x

CAPPALONGA AM, 1994, J. Am. Chem. Soc., 116, 5063, 10.1021/ja00091a006

SMITH GM, 1994, Protein Sci, 3, 118, 10.1002/pro.5560030115

10.1002/pro.5560070303

10.1021/bi970760v

SCOZZAFAVA A, 1999, Med. Chem., 42, 2641, 10.1021/jm9900523

BORRAS J, 1999, Med. Chem., 7, 2397, 10.1016/S0968-0896(99)00190-X

SCOZZAFAVA A, 1999, J. Med. Chem., 42, 3690, 10.1021/jm9901879

SCOZZAFAVA A, 2000, J. Med. Chem., 43, 292, 10.1021/jm990479+

FRIEDENWALD JS, 1949, Am. J. Ophthalmol, 32, 9, 10.1016/S0002-9394(14)78354-0

KINSEY VE, 1953, Arch. Ophthalmol, 50, 401, 10.1001/archopht.1953.00920030409001

KINSEY VE, 1949, II. Derivation of rate of flow and its physiologic signifi-cance. Am. J. Ophthalmol, 32, 189

WISTRAND PJ, 1951, Acta Physic)]. Scand., 24, 144, 10.1111/j.1748-1716.1951.tb00833.x

BECKER B, 1955, Am. J. Ophthalmol, 39, 177, 10.1016/0002-9394(55)90022-2

KINSEY VE, 1959, Arch. Ophthalmol, 62, 78, 10.1001/archopht.1959.04220010082009

10.1016/0163-7258(89)90049-1

MAREN TH, 1995, J. Glaucoma, 4, 49, 10.1097/00061198-199502000-00012

MAREN TH, 1967, Physiol. Rev., 47, 595, 10.1152/physrev.1967.47.4.595

MAREN TH, 1983, Exp. Eye Res., 36, 457, 10.1016/0014-4835(83)90041-6

SUGRUE MF, 2000, Progr. Ret. Eye Res., 19, 87, 10.1016/S1350-9462(99)00006-3

10.1111/j.1600-0536.1998.tb05905.x

10.1001/archopht.117.8.1087

THOE SCHWARTZENBERG GW, 1999, Can. J. Ophthalmol, 34, 93

10.1016/S0002-9394(98)00438-3

MENABUONI L, 1999, Enz. Inhib., 14, 457, 10.3109/14756369909030336

WAYMAN L, 1997, Arch. Ophthalmol, 115, 1368, 10.1001/archopht.1997.01100160538002

ALM A, 1998, Progr. Retinal Eye Res., 17, 291, 10.1016/S1350-9462(97)00003-7

10.1001/archopht.116.1.19

10.1001/archopht.1988.01060140350030

GROVER S, 1997, Retina, 17, 222, 10.1097/00006982-199705000-00009

SPONSEL WE, 1997, Am. J. Ophthalmol, 123, 759, 10.1016/S0002-9394(14)71124-9

ORZALESI N, 1993, A pilot study. Graefes Arch. Clin. Exp. Ophthalmol, 231, 254, 10.1007/BF00919100

GONZALEZ C, 1992, Value of acetazolamide. J. Fr. Ophtalmol, 15, 529

CHUFAN EE, 1999, Farmaco, 54, 838, 10.1016/S0014-827X(99)00096-8

SCARROW AM, 1998, Neurosurgery, 43, 1470

BATTISTINI S, 1999, Neurology, 13, 38, 10.1212/WNL.53.1.38

COWEN MA, 1997, J. Clin. Psychopharmacol, 17, 190, 10.1097/00004714-199706000-00009

CLARKE C, 1988, Int. J. Sports Med., 9, 170, 10.1055/s-2007-1024999

WILNER A, 1999, Epilepsia, 40, 792, 10.1111/j.1528-1157.1999.tb00781.x

GRIGGS RC, 1978, Ann. Neurol., 3, 531, 10.1002/ana.410030614

LINKS TP, 1994, Clinical, diagnostic and therapeutic aspects. Neurol. Sci., 122, 33

UITTI RJ, 1998, Geriatrics, 53, 46

BERNHARD WN, 1998, Aviat. Space Environ. Med., 69, 883

PORCELLI MJ, 1995, J. Am. Osteopath. Assoc., 95, 718, 10.7556/jaoa.1995.95.12.718

LONNERHOLM G, 1985, Gastroenterology, 88, 1151, 10.1016/S0016-5085(85)80074-3

SLY WS, 1995, Ann. Rev. Biochem., 64, 375, 10.1146/annurev.bi.64.070195.002111

SAARNIO J, 1999, J. Histochem. Cytochem., 47, 517, 10.1177/002215549904700410

HENKIN RI, 1999, Am. J. Med. Sci, 318, 380, 10.1016/S0002-9629(15)40663-9

JANOWITZ HD, 1952, Am. J. Physiol., 171, 325, 10.1152/ajplegacy.1952.171.2.325

VINCE JW REITHMEYER RAF, 1998, J. Biol. Chem., 273, 28430, 10.1074/jbc.273.43.28430

ILIES MA, 2000, Part 91. Metal complexes of heterocyclic sulfonamides as potential pharmacol-ogical agents in the treatment of gastric acid secretion imbalances. Metal Based Drugs, 7, 57

MILOV DE, 1992, Hepatology, 15, 288, 10.1002/hep.1840150219

SUPURAN CT, 1996, Eur. J. Med. Chem., 31, 843, 10.1016/S0223-5234(97)89847-9

LONNERHOLM G, 1986, Effects of chronic acetazolamide treatment. Acta Physiol. Scand., 126, 51, 10.1111/j.1748-1716.1986.tb07788.x

TINKER JP, 1981, J. Pharmacol Exptl. Ther., 218, 600

PIERCE WW, 1987, Proc. Soc. Exp. Biol. Med., 186, 96, 10.3181/00379727-186-42590A

TEICHER BA, 1993, AntiCancer Res., 13, 1549

CHEGWIDDEN WR, 1995, Inflammopharmacol, 3, 231, 10.1007/BF02659120

10.1073/pnas.040554897

NOGRADI A, 1998, Am. J. Path., 153, 1, 10.1016/S0002-9440(10)65537-X

TAKI K, 1998, Heart Vessels, 13, 63, 10.1007/BF01744588

GAMBHIR S, 1997, Neurol. Res., 19, 139, 10.1080/01616412.1997.11740787

GROSSMANN WM, 2000, Cerebrovasc. Dis., 10, 65, 10.1159/000016027

BERTHEZENE Y, 1998, Can cerebrovascular reactivity be assessed by dynamic susceptibility contrast-enhanced MRI ? Neuroradiology, 40, 1

DETRE JA, 1999, J. Magn. Reson. Imaging, 10, 870, 10.1002/(SICI)1522-2586(199911)10:5<870::AID-JMRI36>3.0.CO;2-D

HIRANO T, 1994, J. Cereb. Blood Flow Metab., 14, 763, 10.1038/jcbfm.1994.97

HAYASHIDA K, 1996, Nucl. Med. Commun., 17, 1047, 10.1097/00006231-199612000-00008

TAKEUCHI R, 1997, J. Cereb. Blood Flow Metab., 17, 1020, 10.1097/00004647-199710000-00003

LE BARS D, 1988, Appl. RadiaL Isot., 39, 671, 10.1016/0883-2889(88)90056-1

BERGMANN SR, 1998, Semin. Nucl. Med., 28, 320, 10.1016/S0001-2998(98)80036-6

SALVATORI M, 1997, Rays, 22, 51

FREY KA, 1998, Q. J. Nucl. Med., 42, 166

LEINER M, 1940, Naturwiss., 28, 316, 10.1007/BF01734561

KIESE M, 1941, Naturwiss., 29, 116, 10.1007/BF01486163

LEINER M, 1941, Naturwiss., 29, 195, 10.1007/BF01503749

LEINER M, 1941, Biochem. Z, 311, 119

CLARE BW, 1994, 3. Structure-activity correlations for a series of isozyme II activators. J. Pharm. Sci., 83, 768

BRIGANTI F, 1999, Bioorg. Med. Chem. Lett., 9, 2043, 10.1016/S0960-894X(99)00310-8

CHIRICA LC, 1997, Eur. J. Biochem., 244, 755, 10.1111/j.1432-1033.1997.00755.x

HUANG S, 1998, J. Mol Biol., 28, 301, 10.1006/jmbi.1998.2077

EICKHOFF TC, 1966, Antimicrob. Agents Chemother., 6, 389

SANDERS E, 1967, Am. J. Med. Sci., 254, 709, 10.1097/00000441-196711000-00017

VANEECHOUETTE M, 1988, J. Clin. Microbic)]., 26, 2544, 10.1128/JCM.26.12.2544-2548.1988

NAFI BM, 1990, J. Med. Microbic)]., 32, 1, 10.1099/00222615-32-1-1